Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Ikegami

Showing results (11-20 of 367) with videos related to

Pageof 37
Sort By:
Arzneimittel-Forschung|February 1, 1996
Effects of the new selective protein kinase C inhibitor 4'-N-benzoyl staurosporine on cell cycle distribution and growth inhibition in human small cell lung cancer cellsY Ikegami, S Yano, K Nakao
Cell Calcium|February 1, 1991
Fluorescence digital image analysis of serotonin-induced calcium oscillations in single blood plateletsH Nishio, Y Ikegami, T Segawa
Japanese Journal of Pharmacology|January 1, 1996
Antitumor effect of CGP41251, a new selective protein kinase C inhibitor, on human non-small cell lung cancer cellsY Ikegami, S Yano, K Nakao
European Journal of Biochemistry|December 1, 1993
Kinetics of endoglycoceramidase action toward cell-surface glycosphingolipids of erythrocytesM Ito, Y Ikegami, T Yamagata
The Journal of Biological Chemistry|April 25, 1991
Activator proteins for glycosphingolipid hydrolysis by endoglycoceramidases. Elucidation of biological functions of cell-surface glycosphingolipids in situ by endoglycoceramidases made possible using these activator proteinsM Ito, Y Ikegami, T Yamagata
Nippon Ganka Gakkai Zasshi|August 1, 1980
[Studies on dark adaptation in diabetics (1) with special reference to the extent of retinal avascular area (author's transl)]Y Ohtsuka, Y Ikegami, K Ishikawa
Hiroshima Journal of Medical Sciences|August 2, 2000
Invasive bladder cancer after cyclophosphamide administration for nephrotic syndrome--a case reportT Nakamoto, Y Kasaoka, Y Ikegami, et al.
Neurochemistry International|July 1, 1992
Fluorescence digital image analysis of thrombin and ADP induced rise in intracellular Ca2+ concentration of single blood plateletsH Nishio, Y Ikegami, Y Nakata, et al.
Journal of Biochemistry|September 1, 1991
Conversion of endoglycoceramidase-activator II by trypsin to the 27.9 kDa polypeptide possessing full activity: purification of activator for endoglycoceramidase by trypsin treatment followed by trypsin-inhibitor agarose column applicationM Ito, Y Ikegami, A Omori, et al.
Japanese Journal of Cancer Research : Gann|September 1, 1992
Menogaril, an anthracycline derivative, inhibits DNA topoisomerase II by stabilizing cleavable complexesK Ono, Y Ikegami, M Nishizawa, et al.
Pageof 37

Showing results (11-20 of 367) with videos related to

Sort By:
Pageof 37
Arzneimittel-Forschung|February 1, 1996
Effects of the new selective protein kinase C inhibitor 4'-N-benzoyl staurosporine on cell cycle distribution and growth inhibition in human small cell lung cancer cellsY Ikegami, S Yano, K Nakao
Cell Calcium|February 1, 1991
Fluorescence digital image analysis of serotonin-induced calcium oscillations in single blood plateletsH Nishio, Y Ikegami, T Segawa
Japanese Journal of Pharmacology|January 1, 1996
Antitumor effect of CGP41251, a new selective protein kinase C inhibitor, on human non-small cell lung cancer cellsY Ikegami, S Yano, K Nakao
European Journal of Biochemistry|December 1, 1993
Kinetics of endoglycoceramidase action toward cell-surface glycosphingolipids of erythrocytesM Ito, Y Ikegami, T Yamagata
The Journal of Biological Chemistry|April 25, 1991
Activator proteins for glycosphingolipid hydrolysis by endoglycoceramidases. Elucidation of biological functions of cell-surface glycosphingolipids in situ by endoglycoceramidases made possible using these activator proteinsM Ito, Y Ikegami, T Yamagata
Nippon Ganka Gakkai Zasshi|August 1, 1980
[Studies on dark adaptation in diabetics (1) with special reference to the extent of retinal avascular area (author's transl)]Y Ohtsuka, Y Ikegami, K Ishikawa
Hiroshima Journal of Medical Sciences|August 2, 2000
Invasive bladder cancer after cyclophosphamide administration for nephrotic syndrome--a case reportT Nakamoto, Y Kasaoka, Y Ikegami, et al.
Neurochemistry International|July 1, 1992
Fluorescence digital image analysis of thrombin and ADP induced rise in intracellular Ca2+ concentration of single blood plateletsH Nishio, Y Ikegami, Y Nakata, et al.
Journal of Biochemistry|September 1, 1991
Conversion of endoglycoceramidase-activator II by trypsin to the 27.9 kDa polypeptide possessing full activity: purification of activator for endoglycoceramidase by trypsin treatment followed by trypsin-inhibitor agarose column applicationM Ito, Y Ikegami, A Omori, et al.
Japanese Journal of Cancer Research : Gann|September 1, 1992
Menogaril, an anthracycline derivative, inhibits DNA topoisomerase II by stabilizing cleavable complexesK Ono, Y Ikegami, M Nishizawa, et al.
Pageof 37